Adrenomedullin, a new therapeutic target for the treatment of Alzheimer's disease
One of the consequences of the ageing world population is the increase in neurodegenerative diseases such as Alzheimer s or frontotemporal dementia. Neurodegenerative diseases are pathologies characterized by a gradual and irreversible deterioration of neurons and presenting with different neurolog...
Main Authors: | Ferrero-Hidalgo, H. (Hilda), Ramirez, M.J. (María Javier), Gil-Bea, F.J. (Francisco J.) |
---|---|
Format: | info:eu-repo/semantics/doctoralThesis |
Language: | eng |
Published: |
2018
|
Subjects: | |
Online Access: | https://hdl.handle.net/10171/50969 |
Similar Items
-
Targeting JNK for the diagnosis and treatment of Alzheimer's disease
by: Vela-Lumbreras, S. (Silvia), et al.
Published: (2018) -
The compound 33i, a new SIRT2 inhibitor, as a potential treatment for Alzheimer’s disease
by: Díaz-Perdigón, T. (Teresa), et al.
Published: (2019) -
Identification of novel therapeutic strategies for Alzheimer’s disease
by: Pérez-González, M. (Marta), et al.
Published: (2019) -
Design and in vitro / in vivo evaluation of a targeted immunotherapy platform for the treatment of melanoma
by: Merino-Díaz, M. (María), et al.
Published: (2019) -
Efectos de la Estimulación Cognitiva en la Enfermedad de Alzheimer: Implicación de BDNF
by: Gereñu-Lopetegi, G. (Gorka), et al.
Published: (2016)